JCR Pharmaceuticals Co Eulerpool News

JCR Pharmaceuticals Co Aktie News

JCR Pharmaceuticals Co wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten JCR Pharmaceuticals Co News stellen wir hier zusammen.

• 9. Juli ·

  Yahoo
  JCR Pharma and Alexion partner on JUST-AAV gene therapy platform
• 8. Juli ·

  Yahoo
  JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
• 2. Juli ·

  Yahoo
  JCR Pharmaceuticals Announces the Achievement of Enrollment in the JR-141 Global Phase III Clinical Trial
• 24. Juni ·

  Yahoo
  Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by European Commission (EC)
• 6. Juni ·

  Yahoo
  JCR Pharmaceuticals Marks 50 Years of Innovation with Launch of One-of-a-Kind Global Website
• 16. Mai ·

  Yahoo
  JCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising CNS Uptake at American Society of Gene and Cell Therapy 28th Annual Meeting
• 7. Mai ·

  Yahoo
  Notice of Orphan Drug Designation for JR-446 for Mucopolysaccharidosis Type IIIB by the U.S. FDA
• 5. Februar ·

  Yahoo
  JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2025 Showcase Research from Its Investigational Treatments for Lysosomal Storage Disorders
• 28. Januar ·

  Yahoo
  JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025
• 6. Januar ·

  Yahoo
  JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy